Abadie, Roberto. 2010. The professional guinea pig: Big pharma and the risky world of human subjects. Durham: Duke University Press.
Abadie, Roberto. 2015. The “mild-torture economy”: exploring the world of professional research subjects and its ethical implications. Physis: Revista De Saúde Coletiva 25: 709–728.
Ackerman, Terrence F. 1989. An ethical framework for the practice of paying research subjects. IRB: Ethics & Human Research 11 (4): 1–4.
Almeida, Luis, Benedita Azevedo, Teresa Nunes, Manuel Vaz-da-Silva, and Patricio Soares-da-Silva. 2007. Why healthy subjects volunteer for phase I studies and how they perceive their participation? European Journal of Clinical Pharmacology 63 (11): 1085–1094.
Altman, Douglas G. 1980. Statistics and ethics in medical research: III How large a sample? British Medical Journal 281 (6251): 1336–1338.
American Cancer Society Cancer Action Network. 2018. Barriers to patient enrollment in therapeutic clinical trials for cancer: a landscape report. https://www.acscan.org/policy-resources/clinical-trial-barriers. Accessed 28 August 2021.
Anderson, James A., and Charles Weijer. 2002. The research subject as wage earner. Theoretical Medicine and Bioethics 23 (4): 359–376.
Beauchamp, Tom L., and James F. Childress. 2001. The principles of biomedical ethics, 5th ed. Oxford: Oxford University Press.
Belfrage, Sara. 2016. Exploitative, irresistible, and coercive offers: Why research participants should be paid well or not at all. Journal of Global Ethics 12 (1): 69–86.
Bell, Jennifer A.H.., and Lynda G. Balneaves. 2015. Cancer patient decision making related to clinical trial participation: An integrative review with implications for patients’ relational autonomy. Supportive Care in Cancer 23 (4): 1169–1196.
Bentley, John P., and Paul G. Thacker. 2004. The influence of risk and monetary payment on the research participation decision making process. Journal of Medical Ethics 30 (3): 293–298.
Bierer, Barbara E., Sarah A. White, Luke Gelinas, and David H. Strauss. 2021. Fair payment and just benefits to enhance diversity in clinical research. Journal of Clinical and Translational Science 5 (1): e159. https://doi.org/10.1017/cts.2021.816.
Caldwell, Patrina H., Sana Hamilton, Alvin Tan, and Jonathan C. Craig. 2010. Strategies for increasing recruitment to randomised controlled trials: Systematic review. PLoS Medicine 7 (11): e1000368.
Campbell, Marion K., Claire Snowdon, David Francis, Diana R. Elbourne, Alison M. McDonald, Resemary C. Knight, Vikki Entwistle, Jo Garcia, Ian Roberts, and STEPS Group. 2007. Recruitment to randomised trials: Strategies for trial enrolment and participation study. The STEPS study. Health Technology Assessment. https://www.journalslibrary.nihr.ac.uk/hta/hta11480/#/full-report. Accessed 28 Aug 2021.
Carlisle, Benjamin, Jonathan Kimmelman, Tim Ramsay, and Nathalie MacKinnon. 2015. Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials. Clinical Trials 12 (1): 77–83.
Center for Information and Study on Clinical Research Participation. 2019. Charts and statistics. https://www.ciscrp.org/education-center/charts-statistics/. Accessed 28 Aug 2021.
Chambers, Tod. 2001. Participation as commodity, participation as gift. American Journal of Bioethics 1 (2): 48–48.
Chino, Fumiko, and S Yousuf Zafar. 2019. Financial toxicity and equitable access to clinical trials. American Society of Clinical Oncology Educational Book 39: 11–18.
Cooper, Melinda, and Catherine Waldby. 2014. Clinical labor: tissue donors and research subjects in the global bioeconomy. Durham: Duke University Press.
Council for International Organizations of Medical Sciences. 2016. International ethical guidelines for health-related research involving humans. Geneva: Council for International Organizations of Medical Sciences. https://cioms.ch/wp-content/uploads/2017/01/WEB-CIOMS-EthicalGuidelines.pdf. Accessed 28 August 2021.
Council of Europe. 2005a. Additional Protocol to Convention on human rights and biomedicine concerning biomedical research. CETS 195. Strasbourg: Council of Europe. https://rm.coe.int/168008371a. Accessed 28 Aug 2021.
Council of Europe. 2005b. Explanatory report to Additional Protocol to Convention on human rights and biomedicine concerning biomedical research. Strasbourg: Council of Europe. https://rm.coe.int/16800d3810. Accessed 28 Aug 2021.
Cryder, Cynthia E., Alex J. London, Kevin G. Volpp, and George Loewenstein. 2010. Informative inducement: Study payment as a signal of risk. Social Science & Medicine 70 (3): 455–464.
Czarny, Matthew J., Nancy E. Kass, Charles W. Flexner, Kathryn A. Carson, Rachel K. Myers, and Ephraim J. Fuchs. 2010. Payment to healthy volunteers in clinical research: The research subject’s perspective. Clinical Pharmacology & Therapeutics 87 (3): 286–293.
Department of Health and Human Services. 2018. U.S. Code of Federal Regulations, Title 45: Public Welfare, Part 46: Protection of human subjects. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/revised-common-rule-regulatory-text/index.html. Accessed 28 Aug 2021.
Devine, Eric G., Megan E. Waters, Megan Putnam, Caitlin Surprise, Katie O’Malley, Courtney Richambault, Rachel L. Fishmana, Clifford M. Knappa, Elissa H. Pattersona, Ofra Sarid-Segala, Chris Streetera, Laurie Colanaria, and Domenic A. Ciraulo. 2013. Concealment and fabrication by experienced research subjects. Clinical Trials 10 (6): 935–948.
Devine, Eric G., Clifford M. Knapp, Ofra Sarid-Segal, Sean M. O’Keefe, Cale Wardell, Morgan Baskett, Ashley Pecchia, Katie Ferrell, and Domenic A. Ciraulo. 2015. Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information. Contemporary Clinical Trials 41: 55–61.
Dickert, Neal W. 2009. Enrollment of economically disadvantaged participants in clinical research. AMA Journal of Ethics 11 (1): 54–60.
Dickert, Neal W. 2013. Concealment and fabrication: The hidden price of payment for research participation? Clinical Trials 10 (6): 840–841.
Dickert, Neal, Ezekiel Emanuel, and Christine Grady. 2002. Paying research subjects: An analysis of current policies. Annals of Internal Medicine 136 (5): 368–373.
Dickert, Neal, and Christine Grady. 1999. What’s the price of a research subject? Approaches to payment for research participation. The New England Journal of Medicine 341: 198–203.
Dickert, Neal, and Christine Grady. 2008. Incentives for participants. In The Oxford textbook on the ethics of clinical research, ed. Ezekiel J. Emanuel, Robert A. Crouch, Christine C. Grady, Reidar K. Lie, Franklin G. Miller, and David D. Wendler, 386–396. New York: Oxford University Press.
Dresser, Rebecca. 2013. Subversive subjects: Rule-breaking and deception in clinical trials. The Journal of Law, Medicine & Ethics 41 (4): 829–840.
Duncan, Peter. 2010. Health, health care and the problem of intrinsic value. Journal of Evaluation in Clinical Practice 16 (2): 318–322.
Dunn, Laura B., and Nora E. Gordon. 2005. Improving informed consent and enhancing recruitment for research by understanding economic behavior. JAMA 293 (5): 609–612.
Elliott, Carl. 2008. Guinea-pigging. The New Yorker, January 7, pp. 36−41.
Elliott, Carl, and Roberto Abadie. 2008. Exploiting a research underclass in phase 1 clinical trials. The New England Journal of Medicine 358 (22): 2316–2317.
Emanuel, Ezekiel J. 2004. Ending concerns about undue inducement. Journal of Law, Medicine & Ethics 32 (1): 100–105.
Emanuel, Ezekiel J. 2005. Undue inducement: Nonsense on stilts? The American Journal of Bioethics 5 (5): 9–13.
Emanuel, Ezekiel J., David Wendler, and Christine Grady. 2000. What makes clinical research ethical? JAMA 283 (20): 2701–2711.
European Union. 2014. Regulations (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-1/reg_2014_536/reg_2014_536_en.pdf. Accessed 28 Aug 2021.
Faden, Ruth, and Tom Beauchamp. 1986. A history and theory of informed consent. New York: Oxford University Press.
Fisher, Jill A. 2019. Research payment and its social justice concerns. The American Journal of Bioethics 19 (9): 35–36.
Fisher, Jill A., Lisa McManus, Megan M. Wood, Marci D. Cottingham, Julianne M. Kalbaugh, Torin Monahan, and Rebecca L. Walker. 2018. Healthy volunteers’ perceptions of the benefits of their participation in phase I clinical trials. Journal of Empirical Research on Human Research Ethics 13 (5): 494–510.
Fisher, Jill A., Torin Monahan, and Rebecca L. Walker. 2019. Picking and choosing among phase I trials. Journal of Bioethical Inquiry 16 (4): 535–549.
Food and Drug Administration. 2018. Payment and reimbursement to research subjects. Guidance for institutional review boards and clinical investigators. U.S. Food and Drug Administration: Office of the Commissioner, Office of Clinical Policy and Programs, Office of Clinical Policy, Office of Good Clinical Practice. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/payment-and-reimbursement-research-subjects. Accessed 28 Aug 2021.
Friedman, Daniela B., Caroline Foster, Caroline D. Bergeron, Andrea Tanner, and Sei-Hill. Kim. 2015. A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations. American Journal of Health Promotion 29 (5): 332–338.
Fry, Craig L., Alison Ritter, Simon Baldwin, Kathryn J. Bowen, T. Paul Gardiner, Rebecca Jenkinson Holt, and Jennifer Johnston. 2005. Paying research participants: A study of current practices in Australia. Journal of Medical Ethics 31 (9): 542–547.
Gelinas, Luke, Emily A. Largent, I. Glenn Cohen, Susan Kornetsky, Barbara E. Bierer, and Holly Fernandez Lynch. 2018. A framework for ethical payment to research participants. The New England Journal of Medicine 378 (8): 766–771.
Gelinas, Luke, Sarah A. White, and Barbara E. Bierer. 2020. Economic vulnerability and payment for research participation. Clinical Trials 17 (3): 264–272.
Geller, Stacie E., Abby Koch, Beth Pellettieri, and Molly Carnes. 2011. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: Have we made progress? Journal of Women’s Health 20 (3): 315–320.
Glannon, William. 2006. Phase I oncology trials: Why the therapeutic misconception will not go away. Journal of Medical Ethics 32: 252–255.
Grady, Christine. 2001. Money for research participation: Does it jeopardize informed consent? The American Journal of Bioethics 1 (2): 40–44.
Grady, Christine. 2005. Payment of clinical research subjects. The Journal of Clinical Investigation 115 (7): 1681–1687.
Grady, Christine, Gabriella Bedarid, Ninet Sinaii, Mark A. Gregorio, and Ezekiel J. Emanuel. 2017. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research. Clinical Trials 14 (5): 526–536.
Grady, Christine, Neal Dickert, Tom Jawetz, Gary Gensler, and Ezekiel J. Emanuel. 2005. An analysis of US practices of paying research participants. Contemporary Clinical Trials 26 (3): 365–375.
Grant, Ruth W., and Jeremy Sugarman. 2004. Ethics in human subjects research: Do incentives matter? The Journal of Medicine and Philosophy 29 (6): 717–738.
Grimwade, Olivia, Julian Savulescu, Alberto Giubilini, Justin Oakley, Joshua Osowicki, Andrew J. Pollard, and Anne-Marie. Nussberger. 2020. Payment in challenge studies: Ethics, attitudes and a new payment for risk model. Journal of Medical Ethics 46 (12): 815–826.
Gul, Raisa B., and Parveen A. Ali. 2010. Clinical trials: The challenge of recruitment and retention of participants. Journal of Clinical Nursing 19 (1–2): 227–233.
Halpern, Scott D., Jason H.T.. Karlawish, and Jesse A. Berlin. 2002. The continuing unethical conduct of underpowered clinical trials. JAMA 288 (3): 358–362.
Hamel, Lauren M., Louis A. Penner, Terrance L. Albrecht, Elisabeth Heath, Klement C. Gwede, and Susan Eggly. 2016. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control 23 (4): 327–337.
Health Research Authority. 2014. Ethics guidance: payments and incentives in research UK NHS Health Research Authority. National Research and Ethics Advisors' Panel. https://s3.eu-west-2.amazonaws.com/www.hra.nhs.uk/media/documents/hra-guidance-payments-incentives-research.pdf. Accessed 28 Aug 2021.
Heller, Caren, Joyce E. Balls-Berry, Jill D. Nery, Patricia J. Erwin, Dawn Littleton, Mimi Kim, and Winston P. Kuo. 2014. Strategies addressing barriers to clinical trial enrollment of underrepresented populations: A systematic review. Contemporary Clinical Trials 39 (2): 169–182.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2016. ICH Harmonised Guideline Integrated Addendum To ICH E6(R1): Guideline For Good Clinical Practice E6(R2). https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf. Accessed 28 Aug 2021.
Jamrozik, Euzebiusz, and Michael J. Selgelid. 2020. Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants? Journal of Medical Ethics 46 (12): 835–836.
Jones, Eleri, and Kathleen Liddell. 2009. Should healthy volunteers in clinical trials be paid according to risk? Yes. BMJ. https://doi.org/10.1136/bmj.b4142.
King Reame, Nancy. 2001. Treating research subjects as unskilled wage earners: A risky business. American Journal of Bioethics 1 (2): 53–54.
Klitzman, Robert. 2013. How IRBs view and make decisions about coercion and undue influence. Journal of Medical Ethics 39 (4): 224–229.
Kwiatkowski, Kat, Kathlyn Coe, John C. Bailar, and Marie G. Swanson. 2013. Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved? Cancer 119 (16): 2956–2963.
Largent, Emily A., Ezekiel J. Emanuel, and Holly Fernandez Lynch. 2019. Filthy lucre or fitting offer? Understanding worries about payments to research participants. The American Journal of Bioethics 19 (9): 1–4.
Largent, Emily A., Christine Grady, Franklin G. Miller, and Allan Wertheimer. 2012. Money, coercion, and undue inducement: a survey of attitudes about payments to research participants. IRB 34 (1): 1–8.
Largent, Emily A., Christine Grady, Franklin G. Miller, and Allan Wertheimer. 2013. Misconceptions about coercion and undue influence: Reflections on the views of IRB members. Bioethics 27 (9): 500–507.
Largent, Emily A., and Holly Fernandez Lynch. 2017a. Paying research participants: Regulatory uncertainty, conceptual confusion, and a path forward. Yale Journal of Health Policy, Law, and Ethics 17 (1): 61–141.
Largent, Emily A., and Holly Fernandez Lynch. 2017b. Paying research participants: The outsized influence of “undue influence.” IRB 39 (4): 1–9.
Largent, Emily A., and Holly Fernandez Lynch. 2018. Addressing financial barriers to enrollment in clinical trials. JAMA Oncology 4 (7): 913–914.
Lee, Chuen P., Tyson Holmes, Eric Neri, and Clete A. Kushida. 2018. Deception in clinical trials and its impact on recruitment and adherence of study participants. Contemporary Clinical Trials 72: 146–157.
Lemmens, Trudo, and Carl Elliott. 1999. Guinea pigs on the payroll: The ethics of paying research subjects. Accountability in Research 7 (1): 3–20.
Lemmens, Trudo, and Carl Elliott. 2001. Justice for the professional guinea pig. American Journal of Bioethics 1 (2): 51–53.
London, Alex J. 2003. Threats to the common good: Biochemical weapons and human subjects research. Hastings Center Report 33 (5): 17–25.
London, Alex J. 2006. Reasonable risks in clinical research: A critique and a proposal for the Integrative Approach. Statistics in Medicine 25 (17): 2869–2885.
London, Alex J., Jonathan Kimmelman, and Marina E. Emborg. 2010. Beyond access v. protection in trials of innovative therapies. Science 328: 829–830.
Lynch, Holly F. 2014. Human research subjects as human research workers. Yale Journal of Health Policy, Law, and Ethics 14: 122–193.
Lynch, Holly F., Thomas C. Darton, Jae Levy, Frank McCormick, Ubaka Ogbogu, Puth O. Payne, Alvin E. Roth, Akilah Jefferson Shah, Thomas Smiley, and Emily A. Largent. 2021. Promoting ethical payment in human infection challenge studies. The American Journal of Bioethics 21 (3): 11–31.
Lynch, Holly F., Steven Joffe, Harsha Thirumurthy, Dawei Xie, and Emily A. Largent. 2019. Association between financial incentives and participant deception about study eligibility. JAMA Network Open. 2 (1): e187355. https://doi.org/10.1001/jamanetworkopen.2018.7355.
Lynch, Holly F., and Emily A. Largent. 2020. Compensating for research risk: Permissible but not obligatory. Journal of Medical Ethics 46 (12): 827–828.
MacKay, Douglas, and Rebecca L. Walker. 2021. Paying for fairness? Incentives and fair subject selection. The American Journal of Bioethics 21 (3): 35–37.
Macklin, Ruth. 1981. ‘Due’ and ‘undue’ inducements: on paying money to research subjects. IRB: Ethics & Human Research 3 (5): 1–6.
Macklin, Ruth. 1989. The paradoxical case of payment as benefit to research subjects. IRB: Ethics & Human Research 11 (6): 1–3.
Malmqvist, Erik. 2019. “Paid to endure”: Paid research participation, passivity, and the goods of work. The American Journal of Bioethics 19 (9): 11–20.
Manton, Kerry J., Cassandra S. Gauld, Katherine M. White, Paul M. Griffin, and Suzanne L. Elliott. 2019. Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials. British Medical Journal Open 9: e024224. https://doi.org/10.1136/bmjopen-2018-024224.
McCann, Sharon K., Marion K. Campbell, and Vikki A. Entwistle. 2010. Reasons for participating in randomised controlled trials: Conditional altruism and considerations for self. Trials 11 (1): 1–10.
McManus, Lisa, and Jill A. Fisher. 2018. To report or not to report: Exploring healthy volunteers’ rationales for disclosing adverse events in Phase I drug trials. AJOB Empirical Bioethics 9 (2): 82–90.
McNeill, Paul. 1997. Paying people to participate in research: Why not? Bioethics 11 (5): 390–396.
Menikoff, Jerry. 2001. Just compensation: Paying research subjects relative to the risks they bear. The American Journal of Bioethics 1 (2): 56–58.
Miller, Franklin G., and Howard Brody. 2003. A critique of clinical equipoise: Therapeutic misconception in the ethics of clinical trials. The Hastings Center Report 33 (3): 19–28.
Millum, Joseph, and Michael Garnett. 2019. How payment for research participation can be coercive. The American Journal of Bioethics 19 (9): 21–31.
Moriarty, Jeffrey. 2020. What’s in a wage? A new approach to the justification of pay. Business Ethics Quarterly 30 (1): 119–137.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1979. The Belmont report: Ethical principles and guidelines for the protection of human subjects of research. U.S. Department of Health and Human Services. https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/read-the-belmont-report/index.html. Accessed 28 Aug 2021.
National Health and Medical Research Council. 2019. Payment of participation in research: information for researchers, HRECs and other ethics review bodies. Australian Research Council and Universities Australia. Commonwealth of Australia, Canberra. https://www.nhmrc.gov.au/about-us/publications/payment-participants-research-information-researchers-hrecs-and-other-ethics-review-bodies#block-views-block-file-attachments-content-block-1. Accessed 28 Aug 2021.
Ndebele, Paul, Joseph Mfutso-Bengo, and Takafira Mduluza. 2008. Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials: A proposal. Malawi Medical Journal 20 (2): 42–45.
Nipp, Ryan D., Kessely Hong, and Electra D. Paskett. 2019a. Overcoming barriers to clinical trial enrollment. American Society of Clinical Oncology Educational Book 39: 105–114.
Nipp, Ryan D., Hang Lee, Emily Gorton, Morgan Lichtenstein, Salome Kuchukhidze, Elyse Park, Bruce A. Chabner, and Beverly Moy. 2019b. Addressing the financial burden of cancer clinical trial participation: Longitudinal effects of an equity intervention. The Oncologist 24 (8): 1048–1055.
Nuffield Council on Bioethics. 2011. Human bodies: donation for medicine and research. Nuffield Council on Bioethics. https://www.nuffieldbioethics.org/publications/human-bodies-donation-for-medicine-and-research. Accessed 28 Aug 2021.
Nussbaum, Martha C. 2013. Creating capabilities: The human development approach. Cambridge: Harvard University Press.
Parkinson, Beth, Rachel Meacock, Matt Sutton, Eleonora Fichera, Nicola Mills, Gilian W. Shorter, S. Treweek, Nicola L. Harman, Rebecca P. Brown, Katie Gilies, and Peter Bower. 2019. Designing and using incentives to support recruitment and retention in clinical trials: A scoping review and a checklist for design. Trials 20 (1): 1–14.
Pasqualetti, Giuseppe, Giovanni Gori, Corrado Blandizzi, and Mario Del Tacca. 2010. Healthy volunteers and early phases of clinical experimentation. European Journal of Clinical Pharmacology 66 (7): 647–653.
Persad, Govind, Holly Fernandez Lynch, and Emily Largent. 2019. Differential payment to research participants in the same study: An ethical analysis. Journal of Medical Ethics 45 (5): 318–322.
Phillips, Trisha. 2011a. Exploitation in payments to research subjects. Bioethics 25 (4): 209–219.
Phillips, Trisha. 2011b. A living wage for research subjects. The Journal of Law, Medicine & Ethics 3 9(2): 243–253.
Probstfield, Jeffrey L., and Robert L. Frye. 2011. Strategies for recruitment and retention of participants in clinical trials. JAMA 306 (6): 1798–1799.
Radder, Hans. 2017. Which scientific knowledge is a common good? Social Epistemology 31 (5): 431–450.
Rawls, John. 1971. A theory of justice. Cambridge: Harvard University Press.
Resnik, David B. 2011. Scientific research and the public trust. Science and Engineering Ethics 17 (3): 399–409.
Resnik, David B. 2015. Bioethical issues in providing financial incentives to research articipants. Medicolegal and Bioethics 5: 35–41.
Resnik, David B. 2019. Are payments to human research subjects ethically suspect? Journal of Clinical Research Best Practices 15 (6): 2374.
Rhodes, Rosamond. 2010. Rethinking research ethics. The American Journal of Bioethics 10 (10): 19–36.
Ripley, Elizabeth, Francis Macrina, Monika Markowitz, and Chris Gennings. 2010. Why do we pay? A national survey of investigators and IRB chairpersons. Journal of Empirical Research on Human Research Ethics 5 (3): 43–56.
Roche, Eric, Romain King, Helen M. Mohan, Blanaid Gavin, and Fiona McNicholas. 2013. Payment of research participants: Current practice and policies of Irish research ethics committees. Journal of Medical Ethics 39 (9): 591–593.
Różyńska, Joanna. 2015. On the alleged right to participate in high-risk research. Bioethics 29 (7): 451–461.
Różyńska, Joanna. 2018. What makes clinical labour different? The case of human guinea pigging. Journal of Medical Ethics 44 (9): 638–642.
Różyńska, Joanna. 2021. Research participants should be rewarded rather than “compensated for time and burdens.” The American Journal of Bioethics 21 (3): 53–55.
Salman, Rustam A. S. Elaine Beller, Jonathan Kagan, Elina Hemminki, Robert S. Phillips, Julian Savulescu, Malcolm Macleod, Janet Wisley, and Iain Chalmers. 2014. Increasing value and reducing waste in biomedical research regulation and management. The Lancet 383 (9912): 176–185.
Saunders, John. 2009. Should healthy volunteers in clinical trials be paid according to risk? BMJ. https://doi.org/10.1136/bmj.b4145.
Schaefer, G. Owen., Ezekiel J. Emanuel, and Alan Wertheimer. 2009. The obligation to participate in biomedical research. JAMA 302 (1): 67–72.
Shamoo, Adil E., and David B. Resnik. 2006. Strategies to minimize risks and exploitation in phase one trials on healthy subjects. The American Journal of Bioethics 6 (3): W1–W13.
Stones, Martyn, and John McMillan. 2010. Payment for participation in research: a pursuit for the poor? Journal of Medical Ethics 36 (1): 34–36.
Stunkel, Leanne, and Christine Grady. 2011. More than the money: A review of the literature examining healthy volunteer motivations. Contemporary Clinical Trials 32 (3): 342–352.
Sully Ben, G., Steven A. Julious, and Jon A. Nicholl. 2013. A reinvestigation of recruitment to randomised, controlled, multicenter trials: A review of trials funded by two UK funding agencies. Trials 14: 166.
Tishler, Carl L., and Suzanne Bartholomae. 2002. The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. The Journal of Clinical Pharmacology 42 (4): 365–375.
Treweek, Shaun, Pauline Lockhart, Marie Pitkethly, Jonathan A. Cook, Monica Kjeldstrøm, Marit Johansen, Taina K. Taskila, Frank M. Sullivan, Sue Wilson, Catherine Jackson, Ritu Jones, and Elizabeth D. Mitchell. 2013. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and metaanalysis. British Medical Journal Open 3: e002360. https://doi.org/10.1136/bmjopen-2012-002360.
Unger, Joseph M., Julie R. Gralow, Kathy S. Albain, Scott D. Ramsey, and Dawn L. Hershman. 2016. Patient income level and cancer clinical trial participation: A prospective survey study. JAMA Oncology 2 (1): 137–139.
Unger, Joseph M., Dawn L. Hershman, Kathy S. Albain, Carol M. Moinpour, Judith A. Petersen, Kenda Burg, and John J. Crowley. 2013. Patient income level and cancer clinical trial participation. Journal of Clinical Oncology 31 (5): 536–542.
Unger, Joseph M., Riha Vaidya, Dawn L. Hershman, Lori M. Minasian, and Mark E. Fleury. 2019. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. JNCI: Journal of the National Cancer Institute 111 (3): 245–255.
Walker, Rebecca L., and Jill A. Fisher. 2019. “My body is one of the best commodities”: Exploring the ethics of commodification in phase i healthy volunteer clinical trials. Kennedy Institute of Ethics Journal 29 (4): 305–331.
Watson, Judith M., and David J. Torgerson. 2006. Increasing recruitment to randomised trials: A review of randomised controlled trials. BMC Medical Research Methodology 6 (1): 1–9.
Wertheimer, Alan. 2008. Exploitation in clinical research. In The Oxford textbook on the ethics of clinical research, ed. Ezekiel J. Emanuel, Robert A. Crouch, Christine C. Grady, Reidar K. Lie, Franklin G. Miller, and David D. Wendler, 201–210. New York: Oxford University Press.
Wertheimer, Alan. 2013. Is payment a benefit. Bioethics 27: 105–116.
Wertheimer, Alan, and Franklin G. Miller. 2008. Payment for research participation: A coercive offer? Journal of Medical Ethics 34 (5): 389–392.
Wilkinson, Martin, and Andrew Moore. 1997. Inducement in research. Bioethics 11 (5): 373–389.
Williams, Rebecca J., Tony Tse, Katelyn DiPiazza, and Deborah A. Zarin. 2015. Terminated trials in the ClinicalTrials.gov results database: Evaluation of availability of primary outcome data and reasons for termination. PLoS ONE 10 (5): e0127242.
Winter, Stuart S., Janet M. Page-Reeves, Kimberly A. Page, Emily Haozous, Angelica Solares, Carla N. Cordova, and Richard S. Larson. 2018. Inclusion of special populations in clinical research: Important considerations and guidelines. Journal of Clinical and Translational Research 4 (1): 56–69.
World Medical Association (WMA). 2013. Declaration of Helsinki. Ethical principles for medical research involving human subjects. Fortaleza, Brazil. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed 28 Aug 2021.